A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
